TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 299 filers reported holding TANDEM DIABETES CARE INC in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222 | -15.6% | 10,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $263 | -39.5% | 10,700 | 0.0% | 0.00% | -66.7% |
| Q1 2023 | $435 | -9.6% | 10,700 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $481 | -99.9% | 10,700 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $512,000 | -19.1% | 10,700 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $633,000 | -50.5% | 10,700 | -2.7% | 0.00% | -42.9% |
| Q1 2022 | $1,279,000 | -22.8% | 11,000 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $1,656,000 | +25.0% | 11,000 | -0.9% | 0.01% | +14.3% |
| Q3 2021 | $1,325,000 | +22.6% | 11,100 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $1,081,000 | -3.6% | 11,100 | -12.6% | 0.01% | 0.0% |
| Q1 2021 | $1,121,000 | +12.7% | 12,700 | +22.1% | 0.01% | 0.0% |
| Q4 2020 | $995,000 | -15.7% | 10,400 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $1,180,000 | -42.7% | 10,400 | -50.0% | 0.01% | 0.0% |
| Q2 2020 | $2,058,000 | – | 20,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 1,000,000 | $59,610,000 | 47.04% |
| Prospect Capital Advisors, LLC | 127,900 | $7,624,000 | 4.68% |
| Asymmetry Capital Management, L.P. | 43,559 | $2,597,000 | 4.66% |
| Copernicus Capital Management, LLC | 50,000 | $2,981,000 | 3.91% |
| SECTORAL ASSET MANAGEMENT INC | 341,714 | $20,370,000 | 3.04% |
| FRIESS ASSOCIATES LLC | 627,225 | $37,389,000 | 2.60% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,361,345 | $81,150,000 | 2.59% |
| Parkman Healthcare Partners LLC | 134,959 | $8,045,000 | 2.32% |
| OBERWEIS ASSET MANAGEMENT INC/ | 109,940 | $6,554,000 | 2.18% |
| First Light Asset Management, LLC | 268,574 | $16,010,000 | 2.05% |